Back
Swedish Orphan Biovitrum AB 10K Form
Buy
55
BIOVF
Swedish Orphan Biovitrum AB
Last Price:
28.62
Seasonality Move:
5.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BIOVF News And Ratings
See the #1 stock for the next 7 days that we like better than BIOVF
BIOVF Financial Statistics
Sales & Book Value
| Annual Sales: | $1.87B |
|---|---|
| Cash Flow: | $-42.42M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $8.80 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 0.82000 |
|---|---|
| Net Income (TTM): | $296.28M |
| Gross Margin: | $1.4B |
| Return on Equity: | 11.87% |
| Return on Assets: | 5.58% |
Swedish Orphan Biovitrum AB Earnings Forecast
Key Swedish Orphan Biovitrum AB Financial Ratios
- The Gross Profit Margin over the past 21 years for BIOVF is 74.58%.
- The Selling, General & Administrative Expenses for BIOVF have been equal to 41.76% of Gross Profit Margin.
- The Research & Development expenses have been 12.53% of Revenue.
- The Interest Expense is 17.36% of Operating Income.
- The Net Earning history of BIOVF is 14.04% of Total Revenues.
- Per Share Earnings over the last 21 years have been positive in 11 years.
Swedish Orphan Biovitrum AB Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BIOVF |
| Website: | sobi.com |
Debt
| Debt-to-Equity Ratio: | 0.98 |
|---|---|
| Current Ratio: | 0.59 |
| Quick Ratio: | 0.37 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BIOVF Technical Analysis vs Fundamental Analysis
Buy
55
Swedish Orphan Biovitrum AB (BIOVF)
is a Buy
Is Swedish Orphan Biovitrum AB a Buy or a Sell?
-
Swedish Orphan Biovitrum AB stock is rated a Buy
The current Swedish Orphan Biovitrum AB [BIOVF] share price is $28.62. The Score for BIOVF is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.